Cancel

Request a live demo presentation

One of our sales representative will call you soon


By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

We have generated thousand of leads for our happy customers

  • company
  • company
  • company
  • company
  • company
  • company
  • company
  • company

IKSUDA THERAPEUTICS LIMITED Active

Scientific & Education


Contact information


This information is available only for subscribed users

Subscribe

Financial statements of IKSUDA THERAPEUTICS LIMITED

According to IKSUDA THERAPEUTICS LIMITED latest financial report submitted on 2020-12-31, the company has a Cash of £4M, Total-Assets of £8M while the Working-Capital is £5M. Compared with the previous year, the company reported a Cash increase of 82.09%, which is an equivalent of -3323950. At the same time, the Total-Assets went up by 70.53%, or by -5564891.



Consolidated A/cs

For more information you can

Upgrade plan

Turnover 2020

£ -

  • Consolidated A/cs

    N

  • Reporting period

    5

  • Working Capital

    £ 5.5 million

  • Profit after Tax

    £ -

Reporting period Full financial info

IKSUDA THERAPEUTICS LIMITED Business Credit Report

A Business Credit Report for IKSUDA THERAPEUTICS LIMITED is available for instant download. The report will provide you with a credit score and credit limit recommendation for IKSUDA THERAPEUTICS LIMITED, payment trends, if the company pays their Invoices on time, whether or not the company has any court judgements, ownership and group structure, up to 5 years of financial statements and much more. When you buy a Credit Report from Global Database, you will also have a 7 days free trial to our B2B Sales Platform.


Overall Credit Risk for

IKSUDA THERAPEUTICS LIMITED

Unlock Credit Report

For more information you can

Key features

  • Credit Score and Credit Limit
  • Financial accounts for the past 5 years
  • Credit Officers
  • Document Filing history
  • Corporate Ownership
  • Outstanding & Satisfied Mortgages
  • Shareholder Information
  • Company Identity

IKSUDA THERAPEUTICS LIMITED Directors and key executives

View all employees

IKSUDA THERAPEUTICS LIMITED currently employs 16 people. Compared with the previous year, the company has reported a staff increase of 14%, which is an equivalent of 2 employees.
In order to view contact information, including emails and phone numbers for all the employees working at IKSUDA THERAPEUTICS LIMITED and to export them in XL or to your existing CRM, you can subscribe to our platform here.


Total Employee Count

Total employees

16

114%

1y growth

127%

2y growth

Management Level


83

Middle

17

Operational

×
Employee Job Title Email Phone Country
Alan MacKenzie Lamb Director
-
- GB
Michael Owen Director
-
- GB
David Simpson Director
-
- GB
Seung Jeong Director
-
- GB
Jinseok Seo Director
-
- GB

Get in touch with 6 of contacts working at IKSUDA THERAPEUTICS LIMITED

Upgrade to subscription

IKSUDA THERAPEUTICS LIMITED Ownership and Group Structure

View full group structure

IKSUDA THERAPEUTICS LIMITED is a holding company that owns 2 of business within its group, including IKSUDA THERAPE*************, GLYTHERA *******.


IKSUDA THERAPEUTICS LIMITED Shareholders

View all shareholders

There are currently 5 people with significant control at IKSUDA THERAPEUTICS LIMITED. One of of major shareholders of IKSUDA THERAPEUTICS LIMITED is EXECUTORS OF IP2IPO PORTFOLIO LP, which owns 632777 PREFERRED A shares, with a total value of 0 GBP and EXECUTORS OF THE NORTH EAST TECHNOLOGY FUND LP, which owns 39947 ORDINARY A shares, with a total value of 0 GBP and AMY HEPTINSTALL, which owns 411 DEFERRED shares, with a total value of 0 GBP and EMMA POWELL, which owns 756 GROWTH B1 shares, with a total value of 0 GBP and ROBERT LUTZ, which owns 74928 GROWTH B2 shares, with a total value of 0 GBP.


Name Quantity Share Type Value
EXECUTORS OF IP2IPO PORTFOLIO LP 632777 PREFERRED A 0 GBP
EXECUTORS OF THE NORTH EAST TECHNOLOGY FUND LP 39947 ORDINARY A 0 GBP
AMY HEPTINSTALL 411 DEFERRED 0 GBP
EMMA POWELL 756 GROWTH B1 0 GBP
ROBERT LUTZ 74928 GROWTH B2 0 GBP

IKSUDA THERAPEUTICS LIMITED competitors:

View all competitors

Top 5 similar companies of IKSUDA THERAPEUTICS LIMITED are MEDPHARM LIMITED, CHARNWOOD MOLECULAR LIMITED, HVIVO LIMITED, QUOTIENT SCIENCES (ALNWICK) LIMITED, ABZENA LIMITED. View and export all the competitor list of IKSUDA THERAPEUTICS LIMITED by upgrading your account here.


MEDPHARM LIMITED


Revenue
17,876,451.0
Age
23 years
Employees
60
Industry
View Scientific & Education
Website
View www.medpha********

CHARNWOOD MOLECULAR LIMITED


Revenue
6,736,757.0
Age
24 years
Employees
76
Industry
View Scientific & Education
Website
View http://charnwood**************

HVIVO LIMITED


Revenue
-
Age
10 years
Employees
60
Industry
View Scientific & Education
Website
View http://retro**********

QUOTIENT SCIENCES (ALNWICK) LIMITED


Revenue
15,374,000.0
Age
7 years
Employees
175
Industry
View Scientific & Education
Website
View http://arc********

ABZENA LIMITED


Revenue
-
Age
8 years
Employees
3
Industry
View Scientific & Education
Website
View -

IKSUDA THERAPEUTICS LIMITED news & activities:

View full activity

EBITDA

The IKSUDA THERAPEUTICS LIMITED-based company said the adjusted EBITDA is now £102,533.00, compared with the previous year of 135317.

uk.globaldatabase.com

2021-12-31

Employees

IKSUDA THERAPEUTICS LIMITED number of employees has increased by 14% compared with previous year and now represents a total number of 16.

uk.globaldatabase.com

2021-12-31

Frequently Asked Questions regarding IKSUDA THERAPEUTICS LIMITED


Where is IKSUDA THERAPEUTICS LIMITED registered office?

IKSUDA THERAPEUTICS LIMITED is located at THE BIOSPHERE DRAYMANS WAY NEWCASTLE HELIX, United Kingdom.

How can I contact IKSUDA THERAPEUTICS LIMITED?

You can call IKSUDA THERAPEUTICS LIMITED at the following number +441916******

What is the website of IKSUDA THERAPEUTICS LIMITED?

IKSUDA THERAPEUTICS LIMITED website is http://glythera.com

How many people work at IKSUDA THERAPEUTICS LIMITED?

According to the latest account statement, there are currently 16 of employees working for IKSUDA THERAPEUTICS LIMITED.

What is IKSUDA THERAPEUTICS LIMITED EBITDA?

For 2020, IKSUDA THERAPEUTICS LIMITED has reported an EBITDA of £102,533.00, which went up by 31.97% compared to previous year.

What is the Business Credit Score of IKSUDA THERAPEUTICS LIMITED and how reliable is the company?

In order to check the business credit score of IKSUDA THERAPEUTICS LIMITED, you can request a credit report. You will view the latest credit limit information, ownership, group structure, court judgements and much more.

Does IKSUDA THERAPEUTICS LIMITED pay their invoices on time?

By requesting a Business Credit Report for IKSUDA THERAPEUTICS LIMITED, you will be able to gain more insights about the IKSUDA THERAPEUTICS LIMITED payment trends.

Who is the Ultimate Parent of the IKSUDA THERAPEUTICS LIMITED?

Information about the ultimate beneficial ownership IKSUDA THERAPE************* of IKSUDA THERAPEUTICS LIMITED is available when you order a business credit report.

Search for International Credit Report

0 results
Name
Arrow Arrow
City
Arrow Arrow
Address
Arrow Arrow
Reg. No
Arrow Arrow
Status
Arrow Arrow
Action